We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03842228
Brief Title: Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations

First Submitted : February 7, 2019
First Submitted that Met QC Criteria : February 13, 2019
First Posted : February 15, 2019

Last Update Submitted that Met QC Criteria : November 29, 2022
Last Update Posted : November 30, 2022